Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: New Constructs, LLC
$25.00
Provider: Jefferson Research
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Bristol-Myers Squibb Co Prices $1.5 Billion Of Senior Notes


Thursday, 24 Oct 2013 05:19pm EDT 

Bristol-Myers Squibb Company announced today that it has agreed to sell $1.5 billion of senior unsecured notes: $500,000,000 million in aggregate principal amount of 1.750% notes due 2019, $500,000,000 million in aggregate principal amount of 3.250% notes due 2023 and $500,000,000 million in aggregate principal amount of 4.500% notes due 2044, in an underwritten public offering. Deutsche Bank Securities Inc., J.P. Morgan Securities LLC, Barclays Capital Inc., BNP Paribas Securities Corp., Credit Suisse Securities (USA) LLC and RBS Securities Inc. are acting as joint book-running managers of the underwriters. Bristol-Myers Squibb intends to use the net proceeds from the offering for general corporate purposes, including the repayment of all or a portion of its commercial paper borrowings. The offering is expected to close on October 31, 2013, subject to customary closing conditions. 

Company Quote

61.3
0.51 +0.84%
19 Dec 2014